The development of anti-obesity drugs like GLP-1 receptor agonists addresses ... there is a high demand for new and innovative solutions.

GLP-1 weight-loss drugs are cutting calories… and grocery bills, according to a new study from Cornell and Numerator.

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

2024 — Taking anti-obesity drugs has led some U.S. adults to throw away more food than they tossed before starting the medications, a new study has ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

Obesity is associated with an increased risk of VTE, and it has been postulated that standard prophylactic LMWH doses may be insufficient to prevent VTE or achieve suggested anti-factor Xa target ...

COPENHAGEN--Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy ... Wegovy is the first-to-market in a new class of highly effective weight-loss drugs. But analysts say that ...

Eli Lilly has launched a new website-based access programme for some drugs like its new obesity therapy Zepbound ... platforms could violate federal anti-kickback laws. In a new white paper ...

These high-carb foods can enhance your athletic performance and recovery, help you gain weight, boost your metabolism, and ...

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...